Chronic activation of central AMPK attenuates glucose-stimulated insulin secretion and exacerbates hepatic insulin resistance in diabetic rats

Brain Research Bulletin

Volumn 108, Issue , 2014, Pages 18-26

  Park, Sunmin ^a   Kim, Da Sol ^a   Kang, Suna ^a   Shin, Bae Keun ^a  

^a Hoseo University   (South Korea)

Author keywords

AMPK; Energy; Hypothalamus; Insulin; Leptin

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; GLUCOSE; INSULIN; STAT3 PROTEIN; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 3; CARBOHYDRATE; CHEMICAL COMPOUND; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CALORIMETRY; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY EXPENDITURE; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FAT MASS; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HYPERINSULINEMIA; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; MALE; NONHUMAN; OXIDATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RAT; RETROPERITONEAL FAT; THERMOGENESIS; ANIMAL MODEL; APOPTOSIS; CEREBROSPINAL FLUID; EPIDIDYMIS FAT; OSMOTIC PUMP; ANIMAL; BLOOD; DISEASE MODEL; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; LIVER; METABOLISM; PHOSPHORYLATION; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; ENZYME ACTIVATION; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84906735881     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2014.08.002     Document Type: Article

References (35)

1. Burmeister M.A., Ayala J., Drucker D.J., Ayala J.E. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E677-E685.
2. Claret M., Smith M.A., Batterham R.L., Selman C., Choudhury A.I., Fryer L.G., Clements M., Al-Qassab H., Heffron H., Xu A.W., Speakman J.R., Barsh G.S., Viollet B., Vaulont S., Ashford M.L., Carling D., Withers D.J. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J. Clin. Invest. 2007, 117:2325-2336.
3. Cota D., Proulx K., Smith K.A., Kozma S.C., Thomas G., Woods S.C., Woods S.C., Seeley R.J. Hypothalamic mTOR signaling regulates food intake. Science 2006, 312:927-930.
4. Dobbins R.L., Szczepaniak L.S., Myhill J., Tamura Y., Uchino H., Giacca A., McGarry J.D. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 2002, 51:1825-1833.
5. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
6. Flier J.S. Obesity wars, molecular progress confronts an expanding epidemic. Cell 2004, 116:337-350.
7. Han S.M., Namkoong C., Jang P.G., Park I.S., Hong S.W., Katakami H., Chun S., Kim S.W., Park J.Y., Lee K.U., Kim M.S. Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats. Diabetologia 2005, 48:2170-2178.
8. Hardie D.G., Ross F.A., Hawley S.A. AMPK, a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
9. Hosokawa Y.A., Hosokawa H., Chen C., Leahy J.L. Mechanism of impaired glucose-potentiated insulin-secretion in diabetic 90 percent pancreatectomy rats-Study using glucagon-like peptide-1 (7-37). J. Clin. Invest. 1996, 97:180-186.
10. Ikegami M., Ikeda H., Ishikawa Y., Ohsawa M., Ohashi T., Kai M., Kamei A., Kamei J. Olanzapine induces glucose intolerance through the activation of AMPK in the mouse hypothalamus. Eur. J. Pharmacol. 2013, 718:376-382.
11. Karnani M., Burdakov D. Multiple hypothalamic circuits sense and regulate glucose levels. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R47-R55.
12. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., Perret P., Shoelson S.E., Shulman G.I. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 2001, 108:437-446.
13. Kinote A., Faria J.A., Roman E.A., Solon C., Razolli D.S., Ignacio-Souza L.M., Sollon C.S., Nascimento L.F., de Araújo T.M., Barbosa A.P., Lellis-Santos C., Velloso L.A., Bordin S., Anhê G.F. Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels. Endocrinology 2012, 153:3633-3645.
14. Marques M.B., Ribeiro-Oliveira A., Guimarães J., Nascimento G.F., Anjos A.P., Vilas-Boas W.W., Santos R.A., Thomas J.D., Igreja S.M., Grossman A.B., Kola B., Korbonits M. Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker. Stress 2012, 15:554-561.
15. Martins L., Fernández-Mallo D., Novelle M.G., Vázquez M.J., Tena-Sempere M., Nogueiras R., López M., Diéguez C. Hypothalamic mTOR signaling mediates the orexigenic action of ghrelin. PLoS One 2012, 7:e46923.
16. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferré P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
17. Murphy B.A., Fioramonti X., Jochnowitz N., Fakira K., Gagen K., Contie S., Lorsignol A., Penicaud L., Martin W.J., Routh V.H. Fasting enhances the response of arcuate neuropeptide Y-glucose-inhibited neurons to decreased extracellular glucose. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:C746-C756.
18. Niwa H., Ogawa Y., Kido Y., Abe Y., Kobayashi M., Mori T., Tanaka T. The rate of lipid oxidation in septic rat models. Jpn. J. Surg. 1989, 19:439-445.
19. Park S., Hong S.M., Ahn I.S., Kim D.S., Kim S.H. Estrogen replacement reverses olanzapine-induced weight gain and hepatic insulin resistance in ovariectomized diabetic rats. Neuropsychobiology 2010, 61:148-161.
20. Park S., Hong S.M., Ahn I.S., Kim S.H. Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them. J. Psychopharmacol. 2010, 24:1105-1114.
21. Park S., Hong S.M., Sung S.R., Jung H.K. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling. Endocrinology 2008, 149:445-454.
22. Park S., Kim D.S., Kwon D.Y., Yang H.J. Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake. J. Neuroendocrinol. 2011, 23:687-698.
23. Park S., Ahn I.S., Kim D.S. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model. Life Sci. 2010, 86:854-862.
24. Postic C., Dentin R., Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004, 30:398-408.
25. Riediger T. The receptive function of hypothalamic and brainstem centres to hormonal and nutrient signals affecting energy balance. Proc. Nutr. Soc. 2012, 71:463-477.
26. Rizk N.M., Meier D.A., Pastorek D.J., Krakower G.R., Kissebah A.H. Glucose utilization in muscle fiber types, use of the partial pancreatectomized rat model to distinguish effects of glucose and insulin on insulin resistance. Mol. Genet. Metab. 1998, 65:44-50.
27. Ropelle E.R., Fernandes M.F., Flores M.B., Ueno M., Rocco S., Marin R., Cintra D.E., Velloso L.A., Franchini K.G., Saad M.J., Carvalheira J.B. Central exercise action increases the AMPK and mTOR response to leptin. PLoS One 2008, 3:e3856.
28. Sanli T., Steinberg G.R., Sing G., Tsakiridis T. AMP-activated protein kinase (AMPK) beyond metabolism, A novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol. Ther. 2014, 15:156-169.
29. Schneeberger M., Claret M. Recent insights into the role of hypothalamic AMPK signaling cascade upon metabolic control. Front. Neurosci. 2012, 6:185.
30. Stark R., Ashley S.E., Andrews Z.B. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol. Cell Endocrinol. 2013, 366:215-223.
31. Stoppa G.R., Cesquini M., Roman E.A., Prada P.O., Torsoni A.S., Romanatto T., Saad M.J., Velloso L.A., Torsoni M.A. Intracerebroventricular injection of citrate inhibits hypothalamic AMPK and modulates feeding behavior and peripheral insulin signaling. J. Endocrinol. 2008, 198:157-168.
32. Tanida M., Yamamoto N., Shibamoto T., Rahmouni K. Involvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation. PLoS One 2013, 8:e56660.
33. Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes. Metab. 2011, 13:82-88.
34. van den Top M., Lee K., Whyment A.D., Blanks A.M., Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat. Neurosci. 2004, 7:493-494.
35. Yang C.S., Lam C.K., Chari M., Cheung G.W., Kokorovic A., Gao S., Leclerc I., Rutter G.A., Lam T.K. Hypothalamic AMP-activated protein kinase regulates glucose production. Diabetes 2010, 59:2435-2443.